Clinical Trials Logo
  1. Home
  2. Male Hypogonadism
  3. NCT01446042

Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism

Male Hypogonadism Clinical Trial

Official title:
A 90-Day, Randomized, Dose-Ranging Study, Including Potential Dose Titration, Evaluating the Efficacy and Safety of Intranasal TBS-1 in the Treatment of Male Hypogonadism With Sequential Safety Extension Periods of 90 and 180 Days

Clinical Trial Summary

The purpose of this study is to determine the efficacy (based on the pharmacokinetic profile of testosterone) and safety of TBS-1 in the treatment of hypogonadal men

Clinical Trial Description

This study is a 4 Period study consists of 16 visits with overnight clinic stays that span over year to help determine the efficacy of TBS-1 gel administered twice daily (b.i.d) and three times daily (t.i.d)

In addition, this study will investigate the safety and tolerability of TBS-1 after 90, 180 and 360 days of treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01446042
Study type Interventional
Source Acerus Pharmaceuticals Corporation
Contact
Status Completed
Phase Phase 3
Start date September 2011
Completion date March 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT02966652 - Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism Phase 1
Completed NCT01228071 - Time to Eugonadal Range, Time to Steady State and Drying Time Phase 3
Withdrawn NCT02715713 - Autonomic Manifestations of Testosterone Deficiency in Men N/A
Completed NCT00858650 - Registry of Hypogonadism in Men N/A
Recruiting NCT05541172 - Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism
Not yet recruiting NCT04704141 - Relationship of the Microenvironment and Male Fertility
Completed NCT01403116 - Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Phase 3
Completed NCT00911586 - Pharmacokinetic Study to Determine Time to Steady-state Phase 2
Completed NCT00924612 - Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation Phase 2
Completed NCT01765179 - Safety and Efficacy Trial of Testosterone Undecanoate Phase 3
Completed NCT00475501 - 5-Alpha Reductase and Anabolic Effects of Testosterone Phase 2
Completed NCT04708249 - D-chiroinositol Administration in Hypogonadal Males N/A
Completed NCT02081300 - Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism Phase 3
Active, not recruiting NCT03721497 - Testosterone in Bariatric Patients Phase 4
Completed NCT01699178 - Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men Phase 3